Design and characterization of a novel lytic protein against Clostridium difficile

被引：0
|
作者：
Meng Wang
Zifeng Deng
Yanmei Li
Yi Ma
Jufang Wang
机构：
[1] South China University of Technology,School of Biology and Biological Engineering
[2] South China University of Technology,Guangdong Key Laboratory of Fermentation and Enzyme Engineering
来源：
Applied Microbiology and Biotechnology | 2022年 / 106卷
关键词：
Lytic protein; Autolysin; Antibiotic; infection;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4511 / 4521
页数：10
相关论文
共 50 条
  • [1] Design and characterization of a novel lytic protein against Clostridium difficile
    Wang, Meng
    Deng, Zifeng
    Li, Yanmei
    Ma, Yi
    Wang, Jufang
    APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2022, 106 (12) : 4511 - 4521
  • [2] Synthesis and antibacterial activity against Clostridium difficile of novel demethylvancomycin derivatives
    Zhang, Si-Ji
    Yang, Qing
    Xu, Liang
    Chang, Jun
    Sun, Xun
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (15) : 4942 - 4945
  • [3] A novel approach to generate a recombinant toxoid vaccine against Clostridium difficile
    Donald, Robert G. K.
    Flint, Mike
    Kalyan, Narender
    Johnson, Erik
    Witko, Susan E.
    Kotash, Cheryl
    Zhao, Ping
    Megati, Shakuntala
    Yurgelonis, Irina
    Lee, Phillip Kwok
    Matsuka, Yury V.
    Severina, Elena
    Deatly, Anne
    Sidhu, Mini
    Jansen, Kathrin U.
    Minton, Nigel P.
    Anderson, Annaliesa S.
    MICROBIOLOGY-SGM, 2013, 159 : 1254 - 1266
  • [4] Activity of RBx 11760, a novel biaryl oxazolidinone, against Clostridium difficile
    Mathur, Tarun
    Kumar, Manoj
    Barman, Tarani K.
    RamKumar, G.
    Kalia, Vandana
    Singhal, Smita
    Raj, V. Samuel
    Upadhyay, Dilip J.
    Das, Biswajit
    Bhatnagar, Pradip K.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2011, 66 (05) : 1087 - 1095
  • [5] A new treatment against Clostridium difficile
    Erb, William
    Zhu, Jieping
    ACTUALITE CHIMIQUE, 2012, (360): : 83 - 89
  • [6] In Vitro and In Vivo Activities of the Novel Ketolide RBx 14255 against Clostridium difficile
    Kumar, Manoj
    Mathur, Tarun
    Barman, Tarani K.
    Ramkumar, G.
    Bhati, Ashish
    Shukla, Gunjan
    Kalia, Vandana
    Pandya, Manisha
    Raj, V. Samuel
    Upadhyay, Dilip J.
    Vaishnavi, Chetana
    Chakrabarti, Anjan
    Das, Biswajit
    Bhatnagar, Pradip K.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (11) : 5986 - 5989
  • [7] Clostridium difficile flagellin FIiC: Evaluation as adjuvant and use in a mucosal vaccine against Clostridium difficile
    Bruxelle, Jean-Francois
    Mizrahi, Assaf
    Hoys, Sandra
    Collignon, Anne
    Janoir, Claire
    Pechine, Severine
    PLOS ONE, 2017, 12 (11):
  • [8] Efficacy of decontaminants and disinfectants against Clostridium difficile
    Vohra, Prerna
    Poxton, Ian R.
    JOURNAL OF MEDICAL MICROBIOLOGY, 2011, 60 (08) : 1218 - 1224
  • [9] Development and Optimization of a Novel Assay To Measure Neutralizing Antibodies against Clostridium difficile Toxins
    Xie, Jinfu
    Zorman, Julie
    Indrawati, Lani
    Horton, Melanie
    Soring, Keri
    Antonello, Joseph M.
    Zhang, Yuhua
    Secore, Susan
    Miezeiewski, Matthew
    Wang, Su
    Kanavage, Anthony D.
    Skinner, Julie M.
    Rogers, Irene
    Bodmer, Jean-Luc
    Heinrichs, Jon H.
    CLINICAL AND VACCINE IMMUNOLOGY, 2013, 20 (04) : 517 - 525
  • [10] Bis-Cyclic Guanidines as a Novel Class of Compounds Potent against Clostridium difficile
    Li, Chunhui
    Teng, Peng
    Peng, Zhong
    Sang, Peng
    Sun, Xingmin
    Cai, Jianfeng
    CHEMMEDCHEM, 2018, 13 (14) : 1414 - 1420
12345